{"transactions":[{"id":3679050,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-09-09T00:01:03.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":21423,"price":22.22,"value":476019.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":203900,"source":{"system":"sec-edgar","filing":"0001193125-26-385536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836218/000119312526385536/ownership.xml","form_type":"4"}},{"id":844802,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-14T00:05:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":948,"price":17.03,"value":16144.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":225323,"source":{"system":"sec-edgar","filing":"0001193125-26-106703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106703/ownership.xml","form_type":"4"}},{"id":849648,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-12T00:04:04.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":895,"price":16.95,"value":15170.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":226271,"source":{"system":"sec-edgar","filing":"0001193125-26-102703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102703/ownership.xml","form_type":"4"}},{"id":849647,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-12T00:04:04.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":504,"price":16.95,"value":8542.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":227166,"source":{"system":"sec-edgar","filing":"0001193125-26-102703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102703/ownership.xml","form_type":"4"}},{"id":871299,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871298,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":767,"price":16.2,"value":12425.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":227670,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871297,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3718,"price":16.2,"value":60231.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024."}],"balance_after":228437,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871296,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":232155,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":878484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2026-02-28T01:03:03.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001193125-26-083671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526083671/ownership.xml","form_type":"4"}},{"id":994605,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-11-20T01:05:03.000Z","date":"2025-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4582,"price":18.42,"value":84400.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021."}],"balance_after":224030,"source":{"system":"sec-edgar","filing":"0001193125-25-288556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525288556/ownership.xml","form_type":"4"}},{"id":1047171,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:08.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":228612,"source":{"system":"sec-edgar","filing":"0001193125-25-197425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197425/ownership.xml","form_type":"4"}},{"id":1047170,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:08.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 106 shares of common stock purchased on August 31, 2025 through the Company's Employee Stock Purchase Plan"}],"balance_after":178612,"source":{"system":"sec-edgar","filing":"0001193125-25-197425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197425/ownership.xml","form_type":"4"}},{"id":1073482,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2025-08-07T00:01:05.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-104397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025104397/ownership.xml","form_type":"4"}},{"id":1213603,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1213602,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Stock Units","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1213601,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":84631,"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1213600,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2539,"price":100.13,"value":254230.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022."}],"balance_after":76355,"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1213599,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":924,"price":100.13,"value":92520.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":78894,"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1213598,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":79818,"source":{"system":"sec-edgar","filing":"0000950170-25-037523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037523/ownership.xml","form_type":"4"}},{"id":1216325,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Stock Units","published_at":"2025-03-11T00:00:09.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-036694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036694/ownership.xml","form_type":"4"}},{"id":1216324,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:09.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":7990,"price":103.7,"value":828563.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023."}],"balance_after":74318,"source":{"system":"sec-edgar","filing":"0000950170-25-036694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036694/ownership.xml","form_type":"4"}},{"id":1216323,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:09.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":514,"price":103.7,"value":53301.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":82308,"source":{"system":"sec-edgar","filing":"0000950170-25-036694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036694/ownership.xml","form_type":"4"}},{"id":1216322,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:09.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":82822,"source":{"system":"sec-edgar","filing":"0000950170-25-036694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036694/ownership.xml","form_type":"4"}},{"id":1220714,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:03.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":1704,"price":101.34,"value":172683.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":65322,"source":{"system":"sec-edgar","filing":"0000950170-25-035002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035002/ownership.xml","form_type":"4"}},{"id":1232456,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:05.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":715,"price":103.77,"value":74195.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 111 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025."}],"balance_after":67026,"source":{"system":"sec-edgar","filing":"0000950170-25-032759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025032759/ownership.xml","form_type":"4"}},{"id":1270399,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Restricted Stock Units","published_at":"2025-02-14T01:00:06.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-020193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025020193/ownership.xml","form_type":"4"}},{"id":1357832,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-11-21T01:00:03.000Z","date":"2024-11-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4558,"price":102.89,"value":468972.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 47 shares purchased under the Company's registered Employee Stock Purchase Plan on August 30, 2024."}],"balance_after":67630,"source":{"system":"sec-edgar","filing":"0000950170-24-129454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024129454/ownership.xml","form_type":"4"}},{"id":1470015,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:06.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077521/ownership.xml","form_type":"4"}},{"id":1470014,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:06.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077521/ownership.xml","form_type":"4"}},{"id":1470013,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:06.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-077521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077521/ownership.xml","form_type":"4"}},{"id":1470012,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:06.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2182,"price":164.64,"value":359244.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024."}],"balance_after":72141,"source":{"system":"sec-edgar","filing":"0000950170-24-077521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077521/ownership.xml","form_type":"4"}},{"id":1470011,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:06.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":74323,"source":{"system":"sec-edgar","filing":"0000950170-24-077521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077521/ownership.xml","form_type":"4"}},{"id":1585303,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:20.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":909,"price":123.14,"value":111934.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":68073,"source":{"system":"sec-edgar","filing":"0000950170-24-029532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029532/ownership.xml","form_type":"4"}},{"id":1585302,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:20.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":512,"price":120.49,"value":61690.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":68982,"source":{"system":"sec-edgar","filing":"0000950170-24-029532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029532/ownership.xml","form_type":"4"}},{"id":1592832,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-03-07T01:00:09.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":1728,"price":125.32,"value":216552.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":69494,"source":{"system":"sec-edgar","filing":"0000950170-24-027496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024027496/ownership.xml","form_type":"4"}},{"id":1599768,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:07.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":12500,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-026607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026607/ownership.xml","form_type":"4"}},{"id":1599767,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:07.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":71222,"source":{"system":"sec-edgar","filing":"0000950170-24-026607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026607/ownership.xml","form_type":"4"}},{"id":1599766,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:07.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":778,"price":126.19,"value":98175.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 249 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024."}],"balance_after":65222,"source":{"system":"sec-edgar","filing":"0000950170-24-026607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026607/ownership.xml","form_type":"4"}},{"id":1735358,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2023-11-21T01:00:08.000Z","date":"2023-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4508,"price":82.98,"value":374073.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 89 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2023."}],"balance_after":65751,"source":{"system":"sec-edgar","filing":"0001209191-23-056168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123056168/doc4.xml","form_type":"4"}},{"id":1959854,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2023-03-11T01:00:15.000Z","date":"2023-03-08","kind":"tax_withholding","acquired":false,"shares":912,"price":153.19,"value":139709.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":70170,"source":{"system":"sec-edgar","filing":"0001209191-23-018021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123018021/doc4.xml","form_type":"4"}},{"id":1964303,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:50.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":27000,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-017407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017407/doc4.xml","form_type":"4"}},{"id":1964302,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:50.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":71082,"source":{"system":"sec-edgar","filing":"0001209191-23-017407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017407/doc4.xml","form_type":"4"}},{"id":1964301,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:50.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":1134,"price":157.21,"value":178276.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":66582,"source":{"system":"sec-edgar","filing":"0001209191-23-017407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017407/doc4.xml","form_type":"4"}},{"id":1976459,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2023-03-04T01:00:38.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":522,"price":147.57,"value":77031.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 240 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2023."}],"balance_after":67716,"source":{"system":"sec-edgar","filing":"0001209191-23-016054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123016054/doc4.xml","form_type":"4"}},{"id":2109279,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2022-11-22T01:02:02.000Z","date":"2022-11-17","kind":"tax_withholding","acquired":false,"shares":4211,"price":108.52,"value":456977.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 98 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2022."}],"balance_after":67998,"source":{"system":"sec-edgar","filing":"0001209191-22-058284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122058284/doc4.xml","form_type":"4"}},{"id":2345763,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:00:14.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":48000,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-22-017343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017343/doc4.xml","form_type":"4"}},{"id":2345762,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2022-03-09T01:00:14.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":72111,"source":{"system":"sec-edgar","filing":"0001209191-22-017343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017343/doc4.xml","form_type":"4"}},{"id":2345761,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2022-03-09T01:00:14.000Z","date":"2022-03-04","kind":"tax_withholding","acquired":false,"shares":1216,"price":79.2,"value":96307.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":64111,"source":{"system":"sec-edgar","filing":"0001209191-22-017343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017343/doc4.xml","form_type":"4"}},{"id":2367052,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2022-03-02T01:03:42.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":572,"price":75.05,"value":42928.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities directly owned by the reporting person includes 221 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2022."}],"balance_after":65327,"source":{"system":"sec-edgar","filing":"0001209191-22-014409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122014409/doc4.xml","form_type":"4"}},{"id":2493768,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of R&D, CSO"}}],"security":"Common Stock","published_at":"2021-11-29T13:00:34.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":3780,"price":79.33,"value":299867.4,"ownership":{"direct":true},"balance_after":65678,"source":{"system":"sec-edgar","filing":"0001209191-21-066948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121066948/doc4.xml","form_type":"4"}},{"id":2508940,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-18T01:03:46.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities directly owned by the reporting person includes 118 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on August 31, 2021."}],"balance_after":61898,"source":{"system":"sec-edgar","filing":"0001209191-21-065314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121065314/doc4.xml","form_type":"4"}},{"id":2798046,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T01:01:11.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The amount of securities directly owned by the reporting person includes 176 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2021."}],"balance_after":21780,"source":{"system":"sec-edgar","filing":"0001209191-21-019666","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019666/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-05"}},{"id":2798045,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-11T01:01:11.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":565,"price":86.97,"value":49138.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021."}],"balance_after":6604,"source":{"system":"sec-edgar","filing":"0001209191-21-019666","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019666/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-05"}},{"id":2807365,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:05:48.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter."}],"balance_after":60000,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-21-018421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018421/doc4.xml","form_type":"4"}},{"id":2807364,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-06T01:05:48.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date."}],"balance_after":22169,"source":{"system":"sec-edgar","filing":"0001209191-21-018421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018421/doc4.xml","form_type":"4"}},{"id":2947452,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-15T01:05:22.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares of common stock underlying the option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares of common stock underlying such option shall vest and become exercisable on each monthly anniversary of such date of grant thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":169.54,"expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-063360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120063360/doc4.xml","form_type":"4"}}]}